ArticleDiscover oncology2025
Expression of FoxP3 in oral squamous cell carcinoma and its biological significance.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
INTRODUCTION AND
objectiveOral squamous cell carcinoma (OSCC) is a highly malignant tumor that is prone to lymph node metastasis and distant metastasis. FoxP3 is a specific surface marker of regulatory T cells, and its role in various tumors has been confirmed, which is related to tumor progression and prognosis. However, there are relatively few studies on FoxP3 in OSCC, and the role of FoxP3 in OSCC remains unclear. MATERIALS AND
methodsIn this study, the expression of FoxP3 in OSCC was analyzed using data from the TCGA public database. Additionally, 78 OSCC patient samples were analyzed using immunohistochemistry to evaluate the role of FoxP3 in the prognosis of OSCC. The data from TCGA were then investigated using GSEA to explore possible carcinogenic mechanisms. Finally, the online analysis website TIMER was used to analyze the relationship between FoxP3 expression and tumor-associated immune cells.
resultsThe expression of FoxP3 was up-regulated in OSCC tumor tissues, and the expression level was related to the stage of OSCC. The high expression of FoxP3 was associated with better overall survival. FoxP3 expression was positively correlated with the infiltration level of CD4
conclusionsFoxP3 plays an important role in the progression of OSCC and may be related to the prognosis of the tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.